The pharmaceutical company says its sales could be as much as $3 billion lower this year than initially expected. Source link Source link
Read MoreTag: Vaccines
Health Pfizer says results are sufficient to seek approval for the shot, which could be the first deployed against the common respiratory virus Source link Source link
Read MoreRival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies developing […]
Read More